Skin Infections (Topical)
A clinical trial of Promiseb (NCT01214434) found the cream to be safe and significantly efficacious in reducing scaling from baseline to end of treatment when compared with a bland emollient (58%; SD: 62 vs. 90%; SD: 22).
In the clinical trial, upon catheter removal, there were decreases noted in catheter colonization and skin colonization rates.
The favorable in vivo results further confirm the ongoing use of Vibativ for its use in HABP/VABP due to S. aureus, including MRSA.
The Food and Drug Administration (FDA) issued a final rule regarding over-the-counter (OTC) consumer antiseptic wash products containing certain active ingredients.
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ozenoxacin 1% cream (Medimetriks) for the treatment of impetigo.
GlaxoSmithKline announced a recall of 13 lots of Bactroban (mupirocin) Nasal Ointment, Bactroban Ointment, and Bactroban Cream. This recall is a precautionary measure due to potential contamination during manufacturing.
Patients with Staphylococcus aureus skin and soft tissue infections took an average of 57% of their antibiotic doses after being discharged from the hospital, a new study published in Antimicrobial Agents and Chemotherapy reported.
Glenmark has granted final approval from the Food and Drug Administration (FDA) for Clotrimazole and Betamethasone Dipropionate Cream, the generic version of Merck's Lotrisone Cream.
Various dermatological adverse events may occur after acupuncture, with the most common adverse event being infectious skin disease.
Cellulitis is frequently misdiagnosed in the inpatient setting, according to research published in the Journal of the American Academy of Dermatology.
Researchers at the NYU Langone Medical Center have reported that up to six percent of adults in New York who get tattoos have experienced some form of tattoo-related rash, severe itching, or swelling that lasted from four months up to years for some.
A review in the Cochrane Library reviewed existing data from randomized controlled trials on the use of topical antifungals for seborrheic dermatitis in adolescents and adults, with primary outcome measures of complete clearance of symptoms.
Two common antibiotics have been shown to be equally effective in treating uncomplicated community-acquired skin infections like methicillin-resistant Staphylococcus aureus (MRSA), according to a new study in the New England Journal of Medicine.
Merz Dermatology announced that Naftin (naftifine HCl) Gel 2% and Naftin (naftifine HCl) Cream 2% have been approved for the treatment of interdigital type tinea pedis in pediatric patients aged 12-17 years.
Bacteria that are known to cause soft tissue and skin infections have been found in association with hidradenitis suppurativa (HS) lesions.
Amneal announced the launch of four new generic medications: Acyclovir Ointment, Atovaquone Oral Suspension, Clindamycin Palmitate HCl for Oral Solution (Pediatric), and Oxycodone HCl Tablets.
Surgical site infections are associated with significant excess costs, with deep surgical site infections and those in neurosurgery patients have highest costs.
Compared with staple closure, suture closure of the skin after cesarean delivery is associated with a reduced incidence of wound complications.
The top five dermatology-related issues that physicians and patients should question have been released by the American Academy of Dermatology (AAD) as part of the Choosing Wisely campaign.
Amgen announced interim overall survival (OS) results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC, or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).
Valeant announced that the New Drug Application for Luzu (luliconazole) Cream, 1% has been approved by the FDA.
The FDA is requesting label and packaging changes to improve the safety of certain over-the-counter (OTC) topical antiseptic products.